"After Lyco Works asked just a few incisive technical questions, it became clear that we needed to rethink where the technology could be utilized.”

—Pete Canalichio
CEO at Brand Licensing Expert

Modern Design of Experiment & Response Surface Studies for Formulation Development.

November 4th, 2021

You’ve got to eat, so why not log in and learn as you munch? Our speakers Kemal Oflus and Brian Washington (JMP) will walk us through modern Design of Experiment techniques that can explore multiple variables with a minimal number of tests.  Brian will be demonstrating the JMP platform to show how DOE techniques can make work formulation faster, and more efficient.

11:30am – 12:30am Eastern, Friday November 5th via Zoom.

Please register for tomorrow’s Lunch ‘n Learn on statistical experimental design, presented by: JMP a SAS Company. This Zoom meeting is part of the Georgia Local Section of the American Chemical Society event programming.

“Prototype to Profit” ebook by Jason Lye now available on Google Play Books!

July 15th, 2021

Prototype to Profit now available for download on Google Play Books

Bought to life with video footage, case studies, a pop-up glossary and original illustrations, “Prototype to Profit” journeys the path of inventors wishing to commercialize their own product, including budgeting, funding, marketing, deal making with collaborators, creativity-on-demand, intellectual property basics, and IP strategy.  The multimedia book boils down years of experience including new product development, problem solving, intellectual property (IP) strategy, and entrepreneur ship.     Prototype to Profit was completed during the SARS-CoV-2 pandemic, and includes examples of company pivots and adaptations that helped enterprises survive the rough years of Covid-19 lockdown. Published by ACS, the book is included in the inaugural “InFocus” series, brought to life through videos, animations, and “Day in the Life” case studies, delivered in an e-reader that enables learning when it suits you. 

Purchase your copy here.

book cover graphics

Protecting your Investment in New Product Development

May 20th, 2019

For military training purposes, this robust Slingshot device includes novel chemical and electronic technologies to create an explosion, flash, and bang to simulate the effects of real grenades.  This grenade, however, is non-lethal despite the impact of the explosive force it creates.

Lyco Works has been working with Slingshot Product Development Group in Lawrenceville GA recently. Here’s how we’ve been helping their clients develop an IP strategy to help patent protect the new products that Slingshot creates for them…

Read the rest of this entry »

The Dutch Tulip Mania of 1637… Learnings for Pre-Investment Technical Diligence

February 14th, 2019

A tulip bulb could cost a king’s ransom in 17th century Holland – but what lessons can today’s technology investors learn from the 1637 bubble?
Read the rest of this entry »

Broadening Patent Protection – with Human Experience Factors

June 9th, 2018

Please join me on June 20th for a live webinar on Broadening Patent Claims:  Lessons from Automotive and Consumer Goods.

11:00am EDT / 4:00pm BST, Wednesday June 20th

The webinar is free, however, registration is required.  You can register by clicking here.   Looking forward to it!

Read the rest of this entry »

Expanded Chemical Searching Capabilities

April 2nd, 2018

  • How similar are your chemical structures to those mentioned in your competitor’s patents?
  • Who’s running clinical trials on compounds similar to you own?  What stage are they at?
  • Which visually similar chemical compounds are discussed in the patent literature?  Which are not?

With an expanded license to powerful software, we are able to answer these questions for you.  We synthesize these data into a customized dashboard, and add business impact for your specific concerns and needs. Read the rest of this entry »

New Patent Monitoring Service

January 4th, 2018

How well are you keeping up with new IP publications pertinent to your business?

Thousands of patent applications and issued patents publish around the world on a weekly basis.  Of the almost 120,000 patents and applications published weekly in 2017:

    • Which ones may have had financial impact to your business? 
    • Which ones threaten your short and long term competitiveness? 
    • Which ones offer opportunities for future expansion and growth?

Lyco Works now provides a monthly digest, highlighting publications of interest and impact to your business.

A new service offering for 2018.   Read the rest of this entry »

Eye Treatment for Dark Circles and Bags

October 2nd, 2017

Technology for License or Sale

Dr. Cynthia Boxrud formulated a pharmaceutical active into a cream and used it in her plastic surgery practice. She found that it significantly reduced the dark discoloration and swelling under the eyes.

Case #1: Before


Case #2: Before


Four products were developed, and sold on the QVC Shopping Channel. The product was successful in the marketplace, however, Dr. Boxrud made the decision to return to her surgical practice full time, and eventually decided to sell the technology.

Read the rest of this entry »

Concept to Commercialization

September 12th, 2017

Learn how successful entrepreneurs transform an idea into a successful product or service.

Lyco Works, in collaboration with Say Consulting LLC, is proud to announce our 1 day symposium workshop: “The Chemical Entrepreneur :  From Concept to Commercialization.”  With guests invited from industry and academia, Terry Say and I will speak at the Southeastern Regional Meeting of the American Chemical Society (SERMACS), in Charlotte NC on November 9th.  Don’t forget to pre-register for the symposium when you register for the SERMACS conference so that we can provide your lunch.  Read the rest of this entry »

Progress Against Cancer – DNA-Personalized Medicine

August 4th, 2017

In one way or another, very few of us are left untouched by this disease.  As many of you know, it’s been almost a year  since I lost my Dad to cancer (along with several friends, I might add) so I was interested to read in Chemical & Engineering News (C&EN Vol. 95 No. 11 July 3rd, 2017) that a new drug has been approved that treats cancers in any tissue –provided that the patient has a specific genetic profile.  The FDA approval of Keytruda® (Merck & Co.)  illuminates a paradigm shift in the approach to cancer research.  Read the rest of this entry »